---
schema_version: "secwatch.filing_event.v1"
accession: "0001503274-24-000014"
form_type: "8-K"
ticker: "QTRX"
cik: "0001503274"
company_name: "Quanterix Corp"
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T01:48:57.280151+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Quanterix restates prior financials for inventory errors; Q3 revenue $35.7M (+13% YoY)

## Summary
- Revenue $35.7M (+13% YoY); GAAP gross margin 58.9%; reaffirms FY2024 revenue guidance $134-138M.
- Restating financials for 2021-2024 due to inventory capitalization errors; non-reliance on prior statements.
- Estimated restatement impacts: 2023 gross profit +$2.1M, operating loss -$2.3M; no material impact on cash or revenue.
- Material weaknesses in internal control over inventory valuation continue; remediation ongoing.
- Launched LucentAD Complete multi-marker Alzheimer's test; Mt. Sinai deploying blood-based biomarkers using Quanterix assays.

## SEC filing metadata
- accession: 0001503274-24-000014
- form_type: 8-K
- ticker: QTRX
- cik: 0001503274
- company_name: Quanterix Corp
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 4.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1503274/000150327424000014/0001503274-24-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1503274/000150327424000014/qtrx-20241111.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001503274-24-000014
- JSON: https://secwatch.observer/filing/0001503274-24-000014.json
- Plain text: https://secwatch.observer/filing/0001503274-24-000014.txt

## Key facts
- Auditor Changes
  Quanterix Corp reported that prior financial statements should not be relied upon.
  - Action: non reliance
  source text: the need to restate certain previously issued financial statements as further described in Item 4.02 below
  evidence_url: https://www.sec.gov/Archives/edgar/data/1503274/000150327424000014/0001503274-24-000014-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.